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Abstracts / Urological Science 27 (2016) S24eS35 S27cystitis and severe lower urinary tract symptoms (LUTS). We conducted an
in-depth epidemiological study to better understand the correlation be-
tween ketamine abuse and LUTS.
Materials and Methods: The survey was conducted in two private reha-
bilitation centers in Taiwan. Through self-administered questionnaires
(OABSS, IPSS, ICSI, ICPI and VAS), records of inmates, such as gender, age,
and details of using ketamine, including the way, amount, duration of
using ketamine as well as symptoms of urinary tract were obtained. Data
processing and statistical analysis were performed using statistical soft-
ware SPSS v.17. We analyzed all kinds of relative factors causing ketamine
cystitis and off factor, and established an occurrence and severity fore-
casting module.
Results: 106 ketamine abusers completed the questionnaires, including 11
women and 95 men. LUTS occurred after using ketamine for 24.67±26.36
(mean± SD) months. Most of them combined snoring and smoking of the
ketamine. Leading symptoms included frequency (67.3%), incomplete
voiding (66.3%) and nocturia (61.2%). The scores of OABSS, IPSS, ICSI, ICPI
and VAS were 5.23±4.37, 13.11±10.62, 11.47±6.78, 9.92±5.65, 2.89±3.48,
respectively. 79.2% of ketamine abusers admitted a history of poly-
substance abuse, although none of them had taken drugs other than ke-
tamine regularly. Smoking of ketamine was negatively correlated with
symptom scores in IPSS-S, ICSI and ICPI (P<0.05). OABSS signiﬁcantly
increased while combine using ketamine and Marijuana (P¼0.016). Com-
bination with 3,4-methylenedioxy-methamphetamine (MDMA) usage
signiﬁcantly increased the ICPI score (P¼0.034).
Conclusion: Ketamine abuse can induce severe storage symptoms
depending on the duration of using ketamine. Snorting of ketamine may
cause worsen LUTS than smoking. Combine using ketamine and certain
substances may exacerbate LUTS. With this model as a platform, further
prospective studies are warranted to investigate the appropriate choice of
treatment for this new clinical entity.
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EVALUATION OF TREATMENT OUTCOMES IN PELVIC FLOOR MUSCLE
TRAINING WITH BIOFEEDBACK VERSUS INTRA-VAGINAL ELECTRICAL
STIMULATION IN WOMEN WITH URINARY INCONTINENCE IN HONG
KONG PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL
K.W. Yeung, K.L. Lui, W.F. Ho, C.M. Li, C.W. Fan, C.N. Tang.
Purpose: In Hong Kong, the prevalence of Female urinary incontinence is
around 35% and around 18% (~60,000 female) suffered from serve incon-
tinence. However, due to the fact that many women have poor coordina-
tion of pelvic ﬂoor muscle it leads to unsatisfactory treatment outcomes.
Few studies have compared the effectiveness of biofeedback pelvic ﬂoor
muscle training against intra-vaginal electrical stimulation in treating
urinary incontinence.
To evaluate the treatment outcomes and effectiveness of biofeedback
pelvic ﬂoor muscle training against intra-vaginal electrical stimulation for
female patients with urinary incontinence.
Materials and Methods: All patients who attended the female urinary
incontinence clinic from January 2014 to December 2015 were recruited
into the study and the outcomes were analyzed. All patients follow a
standard treatment protocol for the ﬁrst three months, they were taught
how to perform pelvic ﬂoor muscle training, life style modiﬁcation edu-
cation, etiology of urinary incontinence education and initial assessment
of symptom scores (UDI-6, IIQ7), no. of pad used and the time interval
between each micturition were documented. For those patients with poor
outcomes, patient would choose either using biofeedback pelvic ﬂoor
training or intra-vaginal stimulation for further three months. Symptom
scores were reassessed after therapy.
Results: During the study period, 1896 patients were recruited into the
study. Their ages were between 41e83 (mean 58.8). The average duration
of urinary incontinence (UI) was 4.5 years. Forty percent has mixed urinary
incontinence, 48% had stress incontinence and 12% had urge incontinence.
107 patients (5.6%) failed to show any signiﬁcant improvement despite
three months of initial treatment, of which 62 patients (57.9%) were then
proceeded to the intra-vaginal electrical stimulation group and 45 patients
(42.1%) to the biofeedback pelvic ﬂoor muscle-training group. After afurther 12 weeks of treatments, the intra-vaginal stimulation group, had
decreased UDI-6 of 1.4 (P<0.05) and IIQ7 decreased of 1.2 (P<0.05). The
biofeedback pelvic ﬂoor muscle training group had decreased UDI-6 of 2.2
(P<0.05) and IIQ7 of 2.3 (P<0.05). The no. of pad used per day reduced from
2.4 to 1.2(P<0.05) in intra-vaginal stimulation group; 2.3 to 2.1 (P< 0.05)
for the biofeedback pelvic ﬂoor muscle training group. The time interval
between each micturition increased from 1.4 hour to 2.8 hours (P< 0.05)
for both groups.
Conclusion: The results of this study showed that the intra-vaginal
stimulation and biofeedback were both equally effective for poor
responding patients. For the biofeedback group, the symptom scores and
quality of life scores showed better improvement comparing to the intra-
vaginal group. This may be because biofeedback is comparatively more
comfortable than intra-vaginal stimulation, not all patients accept intra-
vaginal probe insertion and for some patients with atrophic vagina,
introduction of probe may be painful. For the actual no. of pad used, the
intra-vaginal stimulation group showed a much more signiﬁcant
improvement. This may be accounted by the fact that direct stimulation
of pelvic ﬂoor muscle is useful for patients with poor active movement.
The drawback of this study is that the treatment options were patient
driven and not randomized but the advantage of patient driven treat-
ment is that patients are very compliance to time consuming rehabili-
tation program.
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Purpose: Bladder outlet obstruction (BOO) is a common cause of over-
active bladder (OAB) symptoms in men, but not all men with OAB symp-
toms have BOO. The strategies for treatment of OAB symptoms are
different in men with BOO and those without BOO. Pressure-ﬂow studies
are considered the reference standard to diagnose BOO. However, the
procedure is invasive, expensive and time-consuming. A non-invasive
diagnostic method for BOO in men with OAB symptoms is warranted. The
nomogram creates a simple graphical representation of a statistically
predictive model which generates a numerical probability of a clinical
event. In this study, we want to develop a nomogram for detection of BOO
in male patients with OAB symptoms.
Materials and Methods: We prospectively recruited male patients pre-
senting with OAB symptoms from our urology outpatient clinic between
August 2008 and July 2015. Patients with overt neurological disorders
were excluded. All patients received the prostate speciﬁc antigen (PSA) test
and transabdominal ultrasound which provided the information of intra-
vesical prostatic protrusion (IPP), prostate volume (PV) and detrusor wall
thickness (DWT). Symptom severity was evaluated with International
Prostate Symptoms Score (IPSS), Overactive Bladder Symptom Score
(OABSS). All patients underwent catheter-free uroﬂowmetry, post-void
residual urine measurement and urodynamic pressure-ﬂow studies. BOO
was deﬁned based on a provisional ICS method for the deﬁnition of
obstruction, which deﬁned BOO as (PdetQmax-2Qmax) > 40. Multivariable
regression analysis was performed to assist in choosing candidate pre-
dictors to build up a nomogram. Internal validation of the nomogram was
performed.
Results: A total of 211 patients were enrolled. The mean age of the patients
was 73.6 years (range 52e91). BOO was diagnosed in 118 patients. Among
univariate analysis, patients with BOO had a higher prevalence of PSA>2
(p¼0.001), PV>30 (p¼0.003), longer IPP (p<0.001), and larger Qmax
(p<0.001), Qmean (p<0.001) on uroﬂowmetry. Among multivariate anal-
ysis, only IPP (p¼0.014) is statistically important, with odds ratio 3.119
(95% CI: 1.259e7.722). A nomogram, demonstrating a predictive accuracy
of 70%, was constructed from PSA, IPP and catheter-free Qmax.
